Sign in
4

Changes in Ownership

Anixa Biosciences Inc Filed Acc 0001493152-23-026125

Chief Executive Officer sold 11,800 shares at $3.57 ($42,126)

  • Chief Executive Officer gave up 28,375 shares (to pay taxes)
  • Chief Executive Officer acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KUMAR AMIT · Chief Executive Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-28 Exercise or conversion : show line 1 in the form +40,000 $2.58 $103,000 502,100 D
2023-07-28 Shares withheld for taxes : show line 2 in the form −28,375 $3.63 $103,001 473,725 D
2023-07-31 Sale : show line 3 in the form −11,800 $3.57 $42,126 461,925 D
Open-market sales · 11,800 sh · avg $3.57 · $42,126

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-07-28 Exercise or conversion : show line 4 in the form Employee Stock Option (Right to Buy) −40,000 0 D
Loading xslF345X05/ownership.xml…